{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Albumin fusion proteins", "Allosteric modulation", "Drug delivery", "Drug specificity", "Human serum albumin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38111902", "DateRevised": {"Year": "2023", "Month": "12", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "27"}], "Language": ["eng"], "ELocationID": ["100114", "10.1016/j.crstbi.2023.100114"], "Journal": {"ISSN": "2665-928X", "JournalIssue": {"Volume": "6", "PubDate": {"Year": "2023"}}, "Title": "Current research in structural biology", "ISOAbbreviation": "Curr Res Struct Biol"}, "ArticleTitle": "Unraveling the versatility of human serum albumin - A comprehensive review of its biological significance and therapeutic potential.", "Pagination": {"StartPage": "100114", "MedlinePgn": "100114"}, "Abstract": {"AbstractText": ["Human serum albumin (HSA) is a multi-domain macromolecule with diverse ligand binding capability because of its ability to allow allosteric modulation despite being a monomeric protein. Physiologically, HSA act as the primary carrier for various exogenous and endogenous compounds and fatty acids, and alter the pharmacokinetic properties of several drugs. It has antioxidant properties and is utilized therapeutically to improve the drug delivery of pharmacological agents for the treatment of several disorders. The flexibility of albumin in holding various types of drugs coupled with a variety of modifications makes this protein a versatile drug carrier with incalculable potential in therapeutics. This review provides a brief outline of the different structural properties of HSA, and its various binding sites, moreover, an overview of the genetic, biomedical, and allosteric modulation of drugs and drug delivery aspects of HSA is also included, which may be helpful in guiding advanced clinical applications and further research on the therapeutic potential of this extraordinary protein."], "CopyrightInformation": "\u00a9 2023 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75210, Pakistan."}], "LastName": "Ashraf", "ForeName": "Sajda", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75210, Pakistan."}], "LastName": "Qaiser", "ForeName": "Hina", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75210, Pakistan."}], "LastName": "Tariq", "ForeName": "Sumayya", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box: 114, Jazan, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Institute, National Center for Research, P.O. Box: 2424, Khartoum, 11111, Sudan."}], "LastName": "Khalid", "ForeName": "Asaad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy Practice Research Unit, Clinical Pharmacy Department, Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia."}], "LastName": "Makeen", "ForeName": "Hafiz A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box: 114, Jazan, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, P.O. Box 114, 45142, Jazan, Saudi Arabia."}], "LastName": "Alhazmi", "ForeName": "Hassan A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75210, Pakistan."}], "LastName": "Ul-Haq", "ForeName": "Zaheer", "Initials": "Z"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Curr Res Struct Biol", "NlmUniqueID": "101767537", "ISSNLinking": "2665-928X"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Adams B., Al Attia H., Khadim R., Al Haider Z. 99Tcm nanocolloid scintigraphy: a reliable way to detect active joint disease in patients with peripheral joint pain. Nucl. Med. Commun. 2001;22(3):315\u2013318.", "ArticleIdList": ["11314764"]}, {"Citation": "Al-Harthi S., Chandra K., Jaremko \u0141. Lipoic Acid restores binding of Zinc ions to human serum albumin. Front. Chem. 2022;10", "ArticleIdList": ["PMC9309503", "35898971"]}, {"Citation": "Alexander M.R., Alexander B., Mustion A.L., Spector R., Wright C.B. Therapeutic use of albumin: 2. JAMA. 1982;247(6):831\u2013833.", "ArticleIdList": ["7057567"]}, {"Citation": "Ascenzi P., Fasano M. Serum heme\u2010albumin: an allosteric protein. IUBMB Life. 2009;61(12):1118\u20131122.", "ArticleIdList": ["19946891"]}, {"Citation": "Ascenzi P., Fasano M. Allostery in a monomeric protein: the case of human serum albumin. Biophys. Chem. 2010;148(1):16\u201322.", "ArticleIdList": ["20346571"]}, {"Citation": "Ascenzi P., Salvati L., Bolognesi M., Colasanti M., Polticelli F., Venturini G. Inhibition of cysteine protease activity by NO-donors. Curr. Protein Pept. Sci. 2001;2(2):137\u2013153.", "ArticleIdList": ["12370021"]}, {"Citation": "Ascenzi P., Bocedi A., Bolli A., Fasano M., Notari S., Polticelli F. Allosteric modulation of monomeric proteins. Biochem. Mol. Biol. Educ. 2005;33(3):169\u2013176.", "ArticleIdList": ["21638571"]}, {"Citation": "Ascenzi P., Bocedi A., Notari S., Fanali G., Fesce R., Fasano M. Allosteric modulation of drug binding to human serum albumin. Mini Rev. Med. Chem. 2006;6(4):483\u2013489.", "ArticleIdList": ["16613585"]}, {"Citation": "Ascenzi P., di Masi A., Coletta M., Ciaccio C., Fanali G., Nicoletti F.P., et al. Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin. J. Biol. Chem. 2009;284(45):31006\u201331017.", "ArticleIdList": ["PMC2781501", "19734142"]}, {"Citation": "Ascenzi P., di Masi A., De Sanctis G., Coletta M., Fasano M. Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites. Biochem. Biophys. Res. Commun. 2009;387(1):83\u201386.", "ArticleIdList": ["19559669"]}, {"Citation": "Bailey M.J., Dickinson R.G. Acyl glucuronide reactivity in perspective: biological consequences. Chem. Biol. Interact. 2003;145(2):117\u2013137.", "ArticleIdList": ["12686489"]}, {"Citation": "Bal W., Soko\u0142owska M., Kurowska E., Faller P. Binding of transition metal ions to albumin: sites, affinities and rates. Biochim. Biophys. Acta Gen. Subj. 2013;1830(12):5444\u20135455.", "ArticleIdList": ["23811338"]}, {"Citation": "Ballantyne F.C., Fleck A., Dick W.C. Albumin metabolism in rheumatoid arthritis. Ann. Rheum. Dis. 1971;30(3):265.", "ArticleIdList": ["PMC1005765", "5090242"]}, {"Citation": "Ballmer P.E., Ochsenbein A.F., Sch\u00fctz-Hofmann S. Transcapillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism. 1994;43(6):697\u2013705.", "ArticleIdList": ["7515458"]}, {"Citation": "Bando Y., Kanehara H., Toya D., Tanaka N., Kasayama S., Koga M. Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease. Ann. Clin. Biochem. 2009;46(5):368\u2013372.", "ArticleIdList": ["19675058"]}, {"Citation": "Bar-Or D., Rael L.T., Lau E.P., Rao N.K., Thomas G.W., Winkler J.V., et al. An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. Biochem. Biophys. Res. Commun. 2001;284(3):856\u2013862.", "ArticleIdList": ["11396981"]}, {"Citation": "Barber M.D., Ross J.A., Fearon K.C. Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr. Cancer. 1999;35(2):106\u2013110.", "ArticleIdList": ["10693162"]}, {"Citation": "Barzegar A., Moosavi-Movahedi A.A., Sattarahmady N., Hosseinpour-Faizi M.A., Aminbakhsh M., Ahmad F., et al. Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding. Protein Pept. Lett. 2007;14(1):13\u201318.", "ArticleIdList": ["17266645"]}, {"Citation": "Bedrosian I., Scheff A.M., Mick R., Callans L.S., Bucky L.P., Spitz F.R., et al. ^ 9^ 9^ mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. J. Nucl. Med. 1999;40:1143\u20131148.", "ArticleIdList": ["10405134"]}, {"Citation": "Belinskaia D.A., Voronina P.A., Shmurak V.I., Jenkins R.O., Goncharov N.V. Serum albumin in health and disease: esterase, antioxidant, transporting and signaling properties. Int. J. Mol. Sci. 2021;22(19)", "ArticleIdList": ["PMC8508759", "34638659"]}, {"Citation": "Bhattacharya A.A., Gr\u00fcne T., Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 2000;303(5):721\u2013732.", "ArticleIdList": ["11061971"]}, {"Citation": "Bhattacharya A.A., Curry S., Franks N.P. Binding of the general anesthetics propofol and halothane to human serum albumin high resolution crystal structures. J. Biol. Chem. 2000;275(49):38731\u201338738.", "ArticleIdList": ["10940303"]}, {"Citation": "Bianchi G., Marchesini G., Zoli M., Bugianesi E., Fabbri A., Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology. 1994;20(1):119\u2013125.", "ArticleIdList": ["8020880"]}, {"Citation": "Bj\u00f6rck L., Kronvall G. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J. Immunol. 1984;133(2):969\u2013974.", "ArticleIdList": ["6234364"]}, {"Citation": "Boonpipattanapong T., Chewatanakornkul S. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J. Clin. Gastroenterol. 2006;40(7):592\u2013595.", "ArticleIdList": ["16917399"]}, {"Citation": "Bos O.J., Fischer M.J., Wilting J., Janssen L.H. Drug-binding and other physicochemical properties of a large tryptic and a large peptic fragment of human serum albumin. Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 1988;953:37\u201347.", "ArticleIdList": ["3124878"]}, {"Citation": "Bos O.J., Remijn J.P., Fischer M.J., Wilting J., Janssen L.H. Location and characterization of the warfarin binding site of human serum albumin: a comparative study of two large fragments. Biochem. Pharmacol. 1988;37(20):3905\u20133909.", "ArticleIdList": ["3190737"]}, {"Citation": "Bourdon E., Loreau N., Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. Faseb. J. 1999;13(2):233\u2013244.", "ArticleIdList": ["9973311"]}, {"Citation": "Bunn H.F., Gabbay K.H., Gallop P.M. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science. 1978;200(4337):21\u201327.", "ArticleIdList": ["635569"]}, {"Citation": "Carter D.C., Ho J.X. Structure of serum albumin. Adv. Protein Chem. 1994;45(45):153\u2013203.", "ArticleIdList": ["8154369"]}, {"Citation": "Carter D.C., He X.-M., Munson S.H., Twigg P.D., Gernert K.M., Broom M.B., et al. Three-dimensional structure of human serum albumin. Science. 1989;244(4909):1195\u20131198.", "ArticleIdList": ["2727704"]}, {"Citation": "Cengiz O., Kocer B., S\u00fcrmeli S., Santicky M.-J., Soran A. Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Med. Sci. Monitor Basic Res. 2006;12(6):CR240\u2013C247.", "ArticleIdList": ["16733481"]}, {"Citation": "Cha M.-K., Kim I.-H. Glutathione-linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma. Biochem. Biophys. Res. Commun. 1996;222(2):619\u2013625.", "ArticleIdList": ["8670254"]}, {"Citation": "Chan B., Dodsworth N., Woodrow J., Tucker A., Harris R. Site\u2010specific N\u2010terminal auto\u2010degradation of human serum albumin. Eur. J. Biochem. 1995;227(1\u20102):524\u2013528.", "ArticleIdList": ["7851432"]}, {"Citation": "Chemmanur A.T., Wu G.Y. Drug evaluation: albuferon-alpha--an antiviral interferon-alpha/albumin fusion protein. Curr. Opin. Invest. Drugs. 2006;7(8):750\u2013758.", "ArticleIdList": ["16955687"]}, {"Citation": "Chen C.B., Hammo B., Barry J., Radhakrishnan K. Overview of albumin physiology and its role in pediatric diseases. Curr. Gastroenterol. Rep. 2021;23(8):11.", "ArticleIdList": ["34213692"]}, {"Citation": "Chiu N.-T., Lee B.-F., Hwang S.-J., Chang J.-M., Liu G.-C., Yu H.-S. Protein-losing enteropathy: diagnosis with 99mTc-labeled human serum albumin scintigraphy 1. Radiology. 2001;219(1):86\u201390.", "ArticleIdList": ["11274540"]}, {"Citation": "Chuang V.T.G., Otagiri M. Flunitrazepam, a 7-nitro-1, 4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin. Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 2001;1546(2):337\u2013345.", "ArticleIdList": ["11295439"]}, {"Citation": "Coban E., Ozdogan M., Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112(3):126\u2013128.", "ArticleIdList": ["15345893"]}, {"Citation": "Cohen M.P. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy? J. Diabet. Complicat. 1988;2(4):214\u2013217.", "ArticleIdList": ["2976766"]}, {"Citation": "Colmenarejo G., Alvarez-Pedraglio A., Lavandera J.-L. Cheminformatic models to predict binding affinities to human serum albumin. J. Med. Chem. 2001;44(25):4370\u20134378.", "ArticleIdList": ["11728183"]}, {"Citation": "Croxson M., Palmer B., Holdaway I., Frengley P., Evans M. Detection of familial dysalbuminaemic hyperthyroxinaemia. BMJ. 1985;290(6475):1099\u20131102.", "ArticleIdList": ["PMC1418734", "3921123"]}, {"Citation": "Curry S. Beyond expansion: structural studies on the transport roles of human serum albumin. Vox Sang. 2002;83(s1):315\u2013319.", "ArticleIdList": ["12617161"]}, {"Citation": "Curry S. Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metabol. Pharmacokinet. 2009;24(4):342\u2013357.", "ArticleIdList": ["19745561"]}, {"Citation": "Curry S., Mandelkow H., Brick P., Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Mol. Biol. 1998;5(9):827\u2013835.", "ArticleIdList": ["9731778"]}, {"Citation": "Czub M.P., Venkataramany B.S., Majorek K.A., Handing K.B., Porebski P.J., Beeram S.R., et al. Testosterone meets albumin\u2013the molecular mechanism of sex hormone transport by serum albumins. Chem. Sci. 2019;10(6):1607\u20131618.", "ArticleIdList": ["PMC6371759", "30842823"]}, {"Citation": "De Chateau M., Bj\u00f6rck L. Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling. J. Biol. Chem. 1994;269(16):12147\u201312151.", "ArticleIdList": ["8163519"]}, {"Citation": "Deng B., Wang Y., Zhu P., Xu X., Ning X. Study of the binding equilibrium between Zn (II) and HSA by capillary electrophoresis\u2013inductively coupled plasma optical emission spectrometry. Anal. Chim. Acta. 2010;683(1):58\u201362.", "ArticleIdList": ["21094381"]}, {"Citation": "Desai N., Trieu V., Yao Z., Louie L., Ci S., Yang A., et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin. Cancer Res. 2006;12(4):1317\u20131324.", "ArticleIdList": ["16489089"]}, {"Citation": "Dhabuwala A., Lamerton P., Stubbs R.S. Relationship of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following Selective Internal Radiation Therapy (SIRT) BMC Med. Phys. 2005;5(1):7.", "ArticleIdList": ["PMC1360059", "16375764"]}, {"Citation": "Di Stefano G., Kratz F., Lanza M., Fiume L. Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier. Dig. Liver Dis. 2003;35(6):428\u2013433.", "ArticleIdList": ["12868680"]}, {"Citation": "Di Stefano G., Derenzini M., Kratz F., Lanza M., Fiume L. Liver\u2010targeted doxorubicin: effects on rat regenerating hepatocytes. Liver Int. 2004;24(3):246\u2013252.", "ArticleIdList": ["15189276"]}, {"Citation": "Dixon M.R., Haukoos J.S., Udani S.M., Naghi J.J., Arnell T.D., Kumar R.R., et al. Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch. Surg. 2003;138(9):962\u2013966.", "ArticleIdList": ["12963652"]}, {"Citation": "D\u00f6m\u00f6t\u00f6r O., Enyedy \u00c9.A. Binding mechanisms of half-sandwich Rh (III) and Ru (II) arene complexes on human serum albumin: a comparative study. JBIC, J. Biol. Inorg. Chem. 2019;24:703\u2013719.", "ArticleIdList": ["PMC6682546", "31300922"]}, {"Citation": "Duff M.R., Jr., Kumar C.V. The metallomics approach: use of Fe (II) and Cu (II) footprinting to examine metal binding sites on serum albumins. Metallomics. 2009;1(6):518\u2013523.", "ArticleIdList": ["21305160"]}, {"Citation": "Elzoghby A.O., Samy W.M., Elgindy N.A. Albumin-based nanoparticles as potential controlled release drug delivery systems. J. Contr. Release. 2012;157(2):168\u2013182.", "ArticleIdList": ["21839127"]}, {"Citation": "Erstad B.L., Gales B.J., Rappaport W.D. The use of albumin in clinical practice. Arch. Intern. Med. 1991;151(5):901\u2013911.", "ArticleIdList": ["1902657"]}, {"Citation": "Evans T. Review article: albumin as a drug\u2014biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol. Therapeut. 2002;16(s5):6\u201311.", "ArticleIdList": ["12423448"]}, {"Citation": "Fanali G., Fesce R., Agrati C., Ascenzi P., Fasano M. Allosteric modulation of myristate and Mn (III) heme binding to human serum albumin. FEBS J. 2005;272(18):4672\u20134683.", "ArticleIdList": ["16156788"]}, {"Citation": "Fanali G., Bocedi A., Ascenzi P., Fasano M. Modulation of heme and myristate binding to human serum albumin by anti\u2010HIV drugs. FEBS J. 2007;274(17):4491\u20134502.", "ArticleIdList": ["17725715"]}, {"Citation": "Fanali G., Di Masi A., Trezza V., Marino M., Fasano M., Ascenzi P. Human serum albumin: from bench to bedside. Mol. Aspect. Med. 2012;33(3):209\u2013290.", "ArticleIdList": ["22230555"]}, {"Citation": "Fasano M., Baroni S., Vannini A., Ascenzi P., Aime S. Relaxometric characterization of human hemalbumin. JBIC, J. Biol. Inorg. Chem. 2001;6(5\u20136):650\u2013658.", "ArticleIdList": ["11472028"]}, {"Citation": "Fasano M., Bocedi A., Mattu M., Coletta M., Ascenzi P. Nitrosylation of rabbit ferrous heme-hemopexin. JBIC, J. Biol. Inorg. Chem. 2004;9(7):800\u2013806.", "ArticleIdList": ["15378409"]}, {"Citation": "Fasano M., Curry S., Terreno E., Galliano M., Fanali G., Narciso P., et al. The extraordinary ligand binding properties of human serum albumin. IUBMB Life. 2005;57(12):787\u2013796.", "ArticleIdList": ["16393781"]}, {"Citation": "Fehske K.J., J\u00e4hnchen E., M\u00fcller W.E., Stillbauer A. Azapropazone binding to human serum albumin. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 1980;313(2):159\u2013163.", "ArticleIdList": ["7422015"]}, {"Citation": "Fehske K.J., M\u00fcller W.E., Wollert U. The location of drug binding sites in human serum albumin. Biochem. Pharmacol. 1981;30(7):687\u2013692.", "ArticleIdList": ["7018498"]}, {"Citation": "Fehske K., Schl\u00e4fer U., Wollert U., M\u00fcller W. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Mol. Pharmacol. 1982;21(2):387\u2013393.", "ArticleIdList": ["6808349"]}, {"Citation": "Fitos I., Visy J., Simonyi M., Hermansson J. Stereoselective allosteric binding interaction on human serum albumin between ibuprofen and lorazepam acetate. Chirality. 1999;11(2):115\u2013120.", "ArticleIdList": ["9951402"]}, {"Citation": "Fiume L., Stefano G.D., Busi C., Mattioli A., Bonino F., Torrani\u2010Cerenzia M., et al. Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor. J. Viral Hepat. 1997;4(6):363\u2013370.", "ArticleIdList": ["9430355"]}, {"Citation": "Fiume L., Bolondi L., Busi C., Chieco P., Kratz F., Lanza M., et al. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. J. Hepatol. 2005;43(4):645\u2013652.", "ArticleIdList": ["16023760"]}, {"Citation": "Gautam A., Gailer J. More effective mobilization of Hg2+ from human serum albumin compared to Cd2+ by L-cysteine at near-physiological conditions. Toxics. 2023;11(7):599.", "ArticleIdList": ["PMC10383730", "37505565"]}, {"Citation": "Gelderblom H., Verweij J., Nooter K., Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer. 2001;37(13):1590\u20131598.", "ArticleIdList": ["11527683"]}, {"Citation": "Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., Curry S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 2005;353(1):38\u201352.", "ArticleIdList": ["16169013"]}, {"Citation": "Giannoukakis N. vol. 4. 2003. pp. 1245\u20131249. (CJC-1131. ConjuChem. Current Opinion in Investigational Drugs (London, England: 2000)). 10.", "ArticleIdList": ["14649218"]}, {"Citation": "Goble S., Bear H.D. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions. Surg. Clin. 2003;83(4):943\u2013971.", "ArticleIdList": ["12875604"]}, {"Citation": "Goldin A., Beckman J.A., Schmidt A.M., Creager M.A. Advanced glycation end products sparking the development of diabetic vascular injury. Circulation. 2006;114(6):597\u2013605.", "ArticleIdList": ["16894049"]}, {"Citation": "GRAM Hansen P., Eriksen J., Mourits\u2010Andersen T., Olesen L. Glycosylated haemoglobin (HbA1c) in iron\u2010and vitamin B12 deficiency. J. Intern. Med. 1990;227(2):133\u2013136.", "ArticleIdList": ["2299304"]}, {"Citation": "Gundry R.L., Fu Q., Jelinek C.A., Van Eyk J.E., Cotter R.J. Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteonomics Clin. Appl. 2007;1(1):73.", "ArticleIdList": ["PMC2831644", "20204147"]}, {"Citation": "Gunturi S.B., Narayanan R., Khandelwal A. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems. Bioorg. Med. Chem. 2006;14(12):4118\u20134129.", "ArticleIdList": ["16504519"]}, {"Citation": "Gupta D., Lis C.G. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr. J. 2010;9(69):10\u20131186.", "ArticleIdList": ["PMC3019132", "21176210"]}, {"Citation": "Haag R., Kratz F. Polymer therapeutics: concepts and applications. Angew. Chem. Int. Ed. 2006;45(8):1198\u20131215.", "ArticleIdList": ["16444775"]}, {"Citation": "Hall L.M., Hall L.H., Kier L.B. Modeling drug albumin binding affinity with e-state topological structure representation. J. Chem. Inf. Comput. Sci. 2003;43(6):2120\u20132128.", "ArticleIdList": ["14632464"]}, {"Citation": "Hall M.L., Jorgensen W.L., Whitehead L. Automated ligand-and structure-based protocol for in silico prediction of human serum albumin binding. J. Chem. Inf. Model. 2013;53(4):907\u2013922.", "ArticleIdList": ["23472823"]}, {"Citation": "Harper M.E., Dugaiczyk A. Linkage of the evolutionarily-related serum albumin and alpha-fetoprotein genes within q11-22 of human chromosome 4. Am. J. Hum. Genet. 1983;35(4):565.", "ArticleIdList": ["PMC1685723", "6192711"]}, {"Citation": "Hennemann G., Krenning E., Otten M., Docter R., Bos G., Visser T. Raised total thyroxine and free thyroxine index but normal free thyroxine: a serum abnormality due to inherited increased affinity of iodothyronines for serum binding protein. Lancet. 1979;313(8117):639\u2013642.", "ArticleIdList": ["85873"]}, {"Citation": "Herv\u00e9 F., Urien S., Albengres E., Duch\u00e9 J.-C., Tillement J.-P. Drug binding in plasma. Clin. Pharmacokinet. 1994;26(1):44\u201358.", "ArticleIdList": ["8137597"]}, {"Citation": "Heys S., Walker L., Deehan D., Eremin E. Serum albumin: a prognostic indicator in patients with colorectal cancer. Age. 1998;38(3) 0.00005.", "ArticleIdList": ["9654876"]}, {"Citation": "Himmelfarb J., McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 2001;60(1):358\u2013363.", "ArticleIdList": ["11422772"]}, {"Citation": "Huang J., Cheng A., Kumar R., Fang Y., Chen G., Zhu Y., et al. Hypoalbuminemia predicts the outcome of COVID\u201019 independent of age and co\u2010morbidity. J. Med. Virol. 2020;92(10):2152\u20132158.", "ArticleIdList": ["PMC7273060", "32406952"]}, {"Citation": "Itoh T., Saura Y., Tsuda Y., Yamada H. Stereoselectivity and enantiomer\u2010enantiomer interactions in the binding of ibuprofen to human serum albumin. Chirality. 1997;9(7):643\u2013649.", "ArticleIdList": ["9366025"]}, {"Citation": "Karimi M., Bahrami S., Ravari S.B., Zangabad P.S., Mirshekari H., Bozorgomid M., et al. Albumin nanostructures as advanced drug delivery systems. Expet Opin. Drug Deliv. 2016;13(11):1609\u20131623.", "ArticleIdList": ["PMC5063715", "27216915"]}, {"Citation": "Kawakami A., Kubota K., Yamada N., Tagami U., Takehana K., Sonaka I., et al. Identification and characterization of oxidized human serum albumin. FEBS J. 2006;273(14):3346\u20133357.", "ArticleIdList": ["16857017"]}, {"Citation": "Kendall F.E. Studies on human serum proteins II. Crystallization of human serum albumin. J. Biol. Chem. 1941;138(1):97\u2013109."}, {"Citation": "Kianfar E. Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles. J. Nanobiotechnol. 2021;19(1):159.", "ArticleIdList": ["PMC8164776", "34051806"]}, {"Citation": "Kim C., Bullard K.M., Herman W.H., Beckles G.L. Association between iron deficiency and A1C levels among adults without diabetes in the national health and nutrition examination survey, 1999\u20132006. Diabetes Care. 2010;33(4):780\u2013785.", "ArticleIdList": ["PMC2845027", "20067959"]}, {"Citation": "Kingston M., Ali M.A., Atiyeh M., Donnelly R. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology. 1984;87(3):688\u2013694.", "ArticleIdList": ["6086443"]}, {"Citation": "Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N. Engl. J. Med. 1976;295(8):417\u2013420.", "ArticleIdList": ["934240"]}, {"Citation": "Koga M., Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr. J. 2010;57(9):751\u2013762.", "ArticleIdList": ["20724796"]}, {"Citation": "Koga M., Murai J., Saito H., Matsumoto S., Kasayama S. Usefullness of glycated albumin as a glycemic control marker after iron treatment for diabetic patients with iron deficiency anemia. J. Jpn. Diabet. Soc. 2009;52:341\u2013345."}, {"Citation": "Koga M., Saito H., Mukai M., Matsumoto S., Kasayama S. Influence of iron metabolism indices on glycated haemoglobin but not glycated albumin levels in premenopausal women. Acta Diabetol. 2010;47(1):65\u201369.", "ArticleIdList": ["19404566"]}, {"Citation": "Kosecki S.M., Rodgers P.T., Adams M.B. Glycemic monitoring in diabetics with sickle cell plus \u03b2-thalassemia hemoglobinopathy. Ann. Pharmacother. 2005;39(9):1557\u20131560.", "ArticleIdList": ["16076916"]}, {"Citation": "Kouzuma T., Uemastu Y., Usami T., Imamura S. Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin. Chim. Acta. 2004;346(2):135\u2013143.", "ArticleIdList": ["15256314"]}, {"Citation": "Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 1981;33(1):17\u201353.", "ArticleIdList": ["7027277"]}, {"Citation": "Kragh-Hansen U. Relations between high-affinity binding sites for L-tryptophan, diazepam, salicylate and Phenol Red on human serum albumin. Biochem. J. 1983;209:135\u2013142.", "ArticleIdList": ["PMC1154064", "6847607"]}, {"Citation": "Kragh-Hansen U. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands. Mol. Pharmacol. 1988;34(2):160\u2013171.", "ArticleIdList": ["3412320"]}, {"Citation": "Kragh-Hansen U., Chuang V.T.G., Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol. Pharm. Bull. 2002;25(6):695\u2013704.", "ArticleIdList": ["12081132"]}, {"Citation": "Kratz F. Drug conjugates with albumin and transferrin. Expert Opin. Ther. Pat. 2002;12(3):433\u2013439."}, {"Citation": "Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Contr. Release. 2008;132(3):171\u2013183.", "ArticleIdList": ["18582981"]}, {"Citation": "Kratz F., Beyer U. Serum proteins as drug carriers of anticancer agents: a review. Drug Deliv. 1998;5(4):281\u2013299.", "ArticleIdList": ["19569996"]}, {"Citation": "Kratz F., Elsadek B. Clinical impact of serum proteins on drug delivery. J. Contr. Release. 2012;161(2):429\u2013445.", "ArticleIdList": ["22155554"]}, {"Citation": "Krebs N.F., Hambidge K., Jacobs M., Rasbach J.O. The effects of a dietary zinc supplement during lactation on longitudinal changes in maternal zinc status and milk zinc concentrations. Am. J. Clin. Nutr. 1985;41(3):560\u2013570.", "ArticleIdList": ["3976555"]}, {"Citation": "Kurtzhals P. Pharmacology of insulin detemir. Endocrinol Metab. Clin. N. Am. 2007;36:14\u201320.", "ArticleIdList": ["17881328"]}, {"Citation": "Lalloz M., Byfield P., Himsworth R. Hyperthyroxinaemia: abnormal binding of T4 by an inherited albumin variant. Clin. Endocrinol. 1983;18(1):11\u201324.", "ArticleIdList": ["6406109"]}, {"Citation": "Lee P., Wu X. Modifications of human serum albumin and their binding effect. Curr. Pharmaceut. Des. 2015;21(14):1862\u20131865.", "ArticleIdList": ["PMC4654954", "25732553"]}, {"Citation": "Lee W.P., Golden M.P., VAN Herle A.J., Lippe B.M., Kaplan S.A. Inherited abnormal thyroid hormone-binding protein causing selective increase of total serum thyroxine. J. Clin. Endocrinol. Metabol. 1979;49(2):292\u2013299.", "ArticleIdList": ["110823"]}, {"Citation": "Lejon S., Frick I.-M., Bj\u00f6rck L., Wikstr\u00f6m M., Svensson S. Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin. J. Biol. Chem. 2004;279(41):42924\u201342928.", "ArticleIdList": ["15269208"]}, {"Citation": "Lien Y.-C., Hsieh C.-C., Wu Y.-C., Hsu H.-S., Hsu W.-H., Wang L.-S., et al. Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J. Gastrointest. Surg. 2004;8(8):1041\u20131048.", "ArticleIdList": ["15585392"]}, {"Citation": "Lipscomb W.N., Str\u00e4ter N. Recent advances in zinc enzymology. Chem. Rev. 1996;96(7):2375\u20132434.", "ArticleIdList": ["11848831"]}, {"Citation": "Lis C.G., Grutsch J.F., Vashi P.G., Lammersfeld C.A. Is serum albumin an independent predictor of survival in patients with breast cancer? J. Parenter. Enteral Nutr. 2003;27(1):10\u201315.", "ArticleIdList": ["12549592"]}, {"Citation": "Loureiro A., G Azoia N., C Gomes A., Cavaco-Paulo A. Albumin-based nanodevices as drug carriers. Curr. Pharmaceut. Des. 2016;22(10):1371\u20131390.", "ArticleIdList": ["26806342"]}, {"Citation": "Melder R.J., Osborn B.L., Riccobene T., Kanakaraj P., Wei P., Chen G., et al. Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice. Cancer Immunol. Immunother. 2005;54(6):535\u2013547.", "ArticleIdList": ["15592670"]}, {"Citation": "Mendez C.M., McClain C.J., Marsano L.S. Albumin therapy in clinical practice. Nutr. Clin. Pract. 2005;20(3):314\u2013320.", "ArticleIdList": ["16207669"]}, {"Citation": "Mera K., Anraku M., Kitamura K., Nakajou K., Maruyama T., Otagiri M. The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst. Biochem. Biophys. Res. Commun. 2005;334(4):1322\u20131328.", "ArticleIdList": ["16054887"]}, {"Citation": "Mikkelsen M., Jacobsen P., Henningsen K. Possible localization of Gc-system on chromosome 4. Loss of long arm 4 material associated with father-child incompatibility within the Gc-system. Hum. Hered. 1977;27(2):105\u2013107.", "ArticleIdList": ["558959"]}, {"Citation": "Minghetti P.P., Ruffner D., Kuang W., Dennison O., Hawkins J.W., Beattie W.G., et al. Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J. Biol. Chem. 1986;261(15):6747\u20136757.", "ArticleIdList": ["3009475"]}, {"Citation": "Musante L., Bruschi M., Candiano G., Petretto A., Dimasi N., Del Boccio P., et al. Characterization of oxidation end product of plasma albumin \u2018in vivo\u2019. Biochem. Biophys. Res. Commun. 2006;349(2):668\u2013673.", "ArticleIdList": ["16949044"]}, {"Citation": "Nakajou K., Watanabe H., Kragh-Hansen U., Maruyama T., Otagiri M. The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochim. Biophys. Acta Gen. Subj. 2003;1623(2\u20133):88\u201397.", "ArticleIdList": ["14572906"]}, {"Citation": "Narazaki R., Otagiri M. Covalent binding of a bucillamine derivative with albumin in sera from healthy subjects and patients with various diseases. Pharmaceut. Res. 1997;14(3):351\u2013353.", "ArticleIdList": ["9098879"]}, {"Citation": "Neelam S., Gokara M., Sudhamalla B., Amooru D.G., Subramanyam R. Interaction studies of coumaroyltyramine with human serum albumin and its biological importance. J. Phys. Chem. B. 2010;114(8):3005\u20133012.", "ArticleIdList": ["20136105"]}, {"Citation": "Neu\u017eil J., Stocker R. Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett. 1993;331(3):281\u2013284.", "ArticleIdList": ["8375511"]}, {"Citation": "Nicoletti F.P., Howes B.D., Fittipaldi M., Fanali G., Fasano M., Ascenzi P., et al. Ibuprofen induces an allosteric conformational transition in the heme complex of human serum albumin with significant effects on heme ligation. J. Am. Chem. Soc. 2008;130(35):11677\u201311688.", "ArticleIdList": ["18681435"]}, {"Citation": "Nishio H., Dugaiczyk A. Complete structure of the human alpha-albumin gene, a new member of the serum albumin multigene family. Proc. Natl. Acad. Sci. USA. 1996;93(15):7557\u20137561.", "ArticleIdList": ["PMC38784", "8755513"]}, {"Citation": "Nishiyama Y., Yamamoto Y., Mori Y., Satoh K., Takashima H., Ohkawa M., et al. Usefulness of Technetium-99m human serum albumin lymphoscintigraphy in chyluria. Clin. Nucl. Med. 1998;23(7):429\u2013431.", "ArticleIdList": ["9676946"]}, {"Citation": "Niwa Y., Iio A., Niwa G., Sakane T., Tsunematsu T., Kanoh T. Serum albumin metabolism in rheumatic diseases: relationship to corticosteroids and peptic ulcer. J. Clin. Lab. Immunol. 1990;31(1):11\u201316.", "ArticleIdList": ["1966978"]}, {"Citation": "Oelshlegel F., Brewer G., Knutsen C., Prasad A., Schoomaker E. Studies on the interaction of zinc with human hemoglobin. Arch. Biochem. Biophys. 1974;163(2):742\u2013748.", "ArticleIdList": ["4415957"]}, {"Citation": "Oettl K., Stauber R. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br. J. Pharmacol. 2007;151(5):580\u2013590.", "ArticleIdList": ["PMC2013999", "17471184"]}, {"Citation": "Onate-Ocana L.F., Aiello-Crocifoglio V., Gallardo-Rincon D., Herrera-Goepfert R., Brom-Valladares R., Carrillo J.F., et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann. Surg Oncol. 2007;14(2):381\u2013389.", "ArticleIdList": ["17160496"]}, {"Citation": "Otagiri M. A molecular functional study on the interactions of drugs with plasma proteins. Drug Metabol. Pharmacokinet. 2005;20(5):309\u2013323.", "ArticleIdList": ["16272748"]}, {"Citation": "Otagiri M., Chuang V.T.G. Pharmaceutically important pre-and posttranslational modifications on human serum albumin. Biol. Pharm. Bull. 2009;32(4):527\u2013534.", "ArticleIdList": ["19336879"]}, {"Citation": "Panzer S., Kronik G., Lechner K., Bettelheim P., Neumann E., Dudczak R. Glycosylated hemoglobins (GHb): an index of red cell survival. Blood. 1982;59(6):1348\u20131350.", "ArticleIdList": ["7082831"]}, {"Citation": "Papatheodorou L., Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxidants Redox Signal. 2007;9(11):1941\u20131958.", "ArticleIdList": ["17822365"]}, {"Citation": "Peters T., Jr. Academic press; 1995. All about Albumin: Biochemistry, Genetics, and Medical Applications."}, {"Citation": "Peters T., Jr. 3 serum albumin. Plasma Proteins 2E V1: Struct. Funct. Genet. Control. 2012;1:133."}, {"Citation": "Petersen C.E., Ha C.-E., Jameson D.M., Bhagavan N.V. Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia. J. Biol. Chem. 1996;271(32):19110\u201319117.", "ArticleIdList": ["8702585"]}, {"Citation": "Petitpas I., Bhattacharya A.A., Twine S., East M., Curry S. Crystal structure analysis of warfarin binding to human serum albumin anatomy of drug site I. J. Biol. Chem. 2001;276(25):22804\u201322809.", "ArticleIdList": ["11285262"]}, {"Citation": "Pomier K.M., Ahmed R., Melacini G. Interactions of intrinsically disordered proteins with the unconventional chaperone human serum albumin: from mechanisms of amyloid inhibition to therapeutic opportunities. Biophys. Chem. 2022;282", "ArticleIdList": ["35093643"]}, {"Citation": "Quinlan G.J., Mumby S., Martin G.S., Bernard G.R., Gutteridge J.M., Evans T.W. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit. Care Med. 2004;32(3):755\u2013759.", "ArticleIdList": ["15090958"]}, {"Citation": "Rabenstein D.L., Isab A.A. The complexation of zinc in intact human erythrocytes studied by 1 H spin-echo NMR. FEBS Lett. 1980;121(1):61\u201364.", "ArticleIdList": ["7461121"]}, {"Citation": "Rahimizadeh P., Yang S., Lim S.I. Albumin: an emerging opportunity in drug delivery. Biotechnol. Bioproc. Eng. 2020;25:985\u2013995."}, {"Citation": "Rang H., Dale M., Ritter J., Moore P. In: How Drugs Act: Molecular Aspects. Pharmacology. fourth ed. rang H.P., Dale M.M., Ritter J.M., editors. Churchill Livingstone Edinburg; London, NY, Philadelphia, Sydney, Toronto: 1999. p. 25."}, {"Citation": "Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 2009;361(9):858\u2013867.", "ArticleIdList": ["19710484"]}, {"Citation": "Rink T., Heuser T., Fitz H., Schroth H.-J., Weller E., Zippel H.H. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol. Clin. Nucl. Med. 2001;26(4):293\u2013298.", "ArticleIdList": ["11290886"]}, {"Citation": "Roche M., Rondeau P., Singh N.R., Tarnus E., Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783\u20131787.", "ArticleIdList": ["18474236"]}, {"Citation": "Roy D., Quiles J., Gaze D., Collinson P., Kaski J., Baxter G. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart. 2006;92(1):113\u2013114.", "ArticleIdList": ["PMC1861004", "16365361"]}, {"Citation": "Sadler P.J., Tucker A., Viles J.H. Involvement of a lysine residue in the N\u2010terminal Ni2+ and Cu2+ binding site of serum albumins. Eur. J. Biochem. 1994;220(1):193\u2013200.", "ArticleIdList": ["8119287"]}, {"Citation": "Sakata N., Moh A., Takebayashi S. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. Heart Ves. 2002;17(1):22\u201329.", "ArticleIdList": ["12434198"]}, {"Citation": "Sampath V., Zhao X.-J., Caughey W.S. Anesthetic-like Interactions of nitric oxide with albumin and hemeproteins a mechanism for control of protein function. J. Biol. Chem. 2001;276(17):13635\u201313643.", "ArticleIdList": ["11278308"]}, {"Citation": "Sbarouni E., Georgiadou P., Voudris V. Ischemia modified albumin changes\u2013review and clinical implications. Clin. Chem. Lab. Med. 2011;49(2):177\u2013184.", "ArticleIdList": ["21083441"]}, {"Citation": "Schleicher E.D., Olgem\u00f6ller B., Wiedenmann E., Gerbitz K. Specific glycation of albumin depends on its half-life. Clin. Chem. 1993;39(4):625\u2013628.", "ArticleIdList": ["8472356"]}, {"Citation": "Sekula B., Ciesielska A., Rytczak P., Kozio\u0142kiewicz M., Bujacz A. Structural evidence of the species-dependent albumin binding of the modified cyclic phosphatidic acid with cytotoxic properties. Biosci. Rep. 2016;36(3)", "ArticleIdList": ["PMC5293571", "27129297"]}, {"Citation": "Seve P., Ray\u2010Coquard I., Trillet\u2010Lenoir V., Sawyer M., Hanson J., Broussolle C., et al. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer. 2006;107(11):2698\u20132705.", "ArticleIdList": ["17063500"]}, {"Citation": "Shaw C.F., III The protein chemistry of antiarthritic gold (I) thiolates and related complexes. Comments Mod. Chem. 1989;8(6):233\u2013267."}, {"Citation": "Shojai S., Haeri Rohani S.-A., Moosavi-Movahedi A.A., Habibi-Rezaei M. Human serum albumin in neurodegeneration. Rev. Neurosci. 2022;33(7):803\u2013817.", "ArticleIdList": ["35363449"]}, {"Citation": "Siddiqui A., Heinzerling J., Livingston E.H., Huerta S. Predictors of early mortality in veteran patients with pancreatic cancer. Am. J. Surg. 2007;194(3):362\u2013366.", "ArticleIdList": ["17693283"]}, {"Citation": "Silverberg J.D., Premachandra B. Familial hyperthyroxinemia due to abnormal thyroid hormone binding. Ann. Intern. Med. 1982;96(2):183\u2013186.", "ArticleIdList": ["6800289"]}, {"Citation": "Simard J.R., Zunszain P.A., Hamilton J.A., Curry S. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. J. Mol. Biol. 2006;361(2):336\u2013351.", "ArticleIdList": ["16844140"]}, {"Citation": "Simons T. Intracellular free zinc and zinc buffering in human red blood cells. J. Membr. Biol. 1991;123(1):63\u201371.", "ArticleIdList": ["1774775"]}, {"Citation": "Soeters P.B., Wolfe R.R., Shenkin A. Hypoalbuminemia: pathogenesis and clinical significance. J. Parenter. Enteral Nutr. 2019;43(2):181\u2013193.", "ArticleIdList": ["PMC7379941", "30288759"]}, {"Citation": "Soko\u0142owska M., Wszelaka-Rylik M., Pozna\u0144ski J., Bal W. Spectroscopic and thermodynamic determination of three distinct binding sites for Co (II) ions in human serum albumin. J. Inorg. Biochem. 2009;103(7):1005\u20131013.", "ArticleIdList": ["19487034"]}, {"Citation": "Soko\u0142owska M., Pawlas K., Bal W. Bioinorganic Chemistry and Applications. 2010. Effect of common buffers and heterocyclic ligands on the binding of Cu (II) at the multimetal binding site in human serum albumin; p. 2010.", "ArticleIdList": ["PMC2864911", "20467459"]}, {"Citation": "Stamler J.S. S-nitrosothiols in the blood roles, amounts, and methods of analysis. Circ. Res. 2004;94(4):414\u2013417.", "ArticleIdList": ["15001539"]}, {"Citation": "Stehle G., Sinn H., Wunder A., Schrenk H.H., Stewart J.C.M., Hartung G., et al. Plasma protein (albumin) catabolism by the tumor itself\u2014implications for tumor metabolism and the genesis of cachexia. Crit. Rev. Oncol.-Hematol. 1997;26(2):77\u2013100.", "ArticleIdList": ["9298326"]}, {"Citation": "Stockigt J.R., Topliss D.J., Barlow J.W., White E.L., Hurley D.M., Taft P. Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin. J. Clin. Endocrinol. Metabol. 1981;53(2):353\u2013359.", "ArticleIdList": ["6166631"]}, {"Citation": "Subramanian G.M., Fiscella M., Lamous\u00e9-Smith A., Zeuzem S., McHutchison J.G. Albinterferon \u03b1-2b: a genetic fusion protein for the treatment of chronic hepatitis C. Nat. Biotechnol. 2007;25(12):1411\u20131419.", "ArticleIdList": ["18066038"]}, {"Citation": "Sudlow G., Birkett D., Wade D. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 1975;11(6):824\u2013832.", "ArticleIdList": ["1207674"]}, {"Citation": "Sudlow G., Birkett D., Wade D. Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 1976;12(6):1052\u20131061.", "ArticleIdList": ["1004490"]}, {"Citation": "Suga K., Kume N., Matsunaga N., Motoyama K., Hara A., Ogasawara N. Assessment of leg oedema by dynamic lymphoscintigraphy with intradermal injection of technetium-99m human serum albumin and load produced by standing. Eur. J. Nucl. Med. 2001;28(3):294\u2013303.", "ArticleIdList": ["11315596"]}, {"Citation": "Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. Crystal structure of human serum albumin at 2.5 \u00c5 resolution. Protein Eng. 1999;12(6):439\u2013446.", "ArticleIdList": ["10388840"]}, {"Citation": "Sun L.-C., Chu K.-S., Cheng S.-C., Lu C.-Y., Kuo C.-H., Hsieh J.-S., et al. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer. 2009;9(1):288.", "ArticleIdList": ["PMC2745428", "19691850"]}, {"Citation": "Sunthornthepvarakul T., Angkeow P., Weiss R.E., Hayashi Y., Refetoff S. An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in eight unrelated families. Biochem. Biophys. Res. Commun. 1994;202(2):781\u2013787.", "ArticleIdList": ["8048949"]}, {"Citation": "Tao H-y, Wang R-q, Sheng W-j, Zhen Y-s. The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy. Int. J. Biol. Macromol. 2021;187:24\u201334.", "ArticleIdList": ["34284054"]}, {"Citation": "Terawaki H., Yoshimura K., Hasegawa T., Matsuyama Y., Negawa T., Yamada K., et al. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int. 2004;66(5):1988\u20131993.", "ArticleIdList": ["15496170"]}, {"Citation": "Tibaduiza E.C., Bobilya D.J. Zinc transport across an endothelium includes vesicular cotransport with albumin. J. Cell. Physiol. 1996;167(3):539\u2013547.", "ArticleIdList": ["8655607"]}, {"Citation": "Tullis J.L. Albumin: 1. Background and use. JAMA. 1977;237(4):355\u2013360.", "ArticleIdList": ["576167"]}, {"Citation": "Van Campenhout A., Van Campenhout C., Lagrou A.R., Moorkens G., De Block C., Manuel-y-Keenoy B. Iron-binding antioxidant capacity is impaired in diabetes mellitus. Free Radic. Biol. Med. 2006;40(10):1749\u20131755.", "ArticleIdList": ["16678014"]}, {"Citation": "van Reyk D.M., Brown A.J., Hult'en L.M., Dean R.T., Jessup W. Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox Rep. 2006;11(6):255\u2013262.", "ArticleIdList": ["17207307"]}, {"Citation": "Vorum H. Reversible ligand binding to human serum albumin. Theoretical and clinical aspects. Dan. Med. Bull. 1999;46(5):379\u2013399.", "ArticleIdList": ["10605618"]}, {"Citation": "Vorum H., Honor\u00e9 B. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy. J. Pharm. Pharmacol. 1996;48(8):870\u2013875.", "ArticleIdList": ["8887741"]}, {"Citation": "Walter P.B., Fung E.B., Killilea D.W., Jiang Q., Hudes M., Madden J., et al. Oxidative stress and inflammation in iron\u2010overloaded patients with \u03b2\u2010thalassaemia or sickle cell disease. Br. J. Haematol. 2006;135(2):254\u2013263.", "ArticleIdList": ["PMC2185791", "17010049"]}, {"Citation": "Watanabe H., Tanase S., Nakajou K., Maruyama T., Kragh-Hansen U., Otagiri M. Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem. J. 2000;349(3):813\u2013819.", "ArticleIdList": ["PMC1221209", "10903143"]}, {"Citation": "Weiss R., Sunthornthepvarakul T., Angkeow P., Marcus-Bagley D., Cox N., Alper C.A., et al. Linkage of familial dysalbuminemic hyperthyroxinemia to the albumin gene in a large Amish kindred. J. Clin. Endocrinol. Metabol. 1995;80(1):116\u2013121.", "ArticleIdList": ["7829599"]}, {"Citation": "Wiedermann C.J. Hypoalbuminemia as surrogate and culprit of infections. Int. J. Mol. Sci. 2021;22(9):4496.", "ArticleIdList": ["PMC8123513", "33925831"]}, {"Citation": "Wilding G., Feldhoff R.C., Vesell E.S. Concentration-dependent effects of fatty acids on warfarin binding to albumin. Biochem. Pharmacol. 1977;26(12):1143\u20131146.", "ArticleIdList": ["560850"]}, {"Citation": "Wilkinson P., Jeremy R., Brooks F.P., Hollander J.L. The mechanism of hypoalbuminemia in rheumatoid arthritis. Ann. Intern. Med. 1965;63(1):109\u2013114.", "ArticleIdList": ["14305957"]}, {"Citation": "Wu T.-W., Wu J., Li R.-K., Mickle D., Carey D. Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem. Cell. Biol. 1991;69(10\u201311):683\u2013688.", "ArticleIdList": ["1799433"]}, {"Citation": "Wu D., Gucwa M., Czub M.P., Cooper D.R., Shabalin I.G., Fritzen R., et al. Structural and biochemical characterisation of Co 2+-binding sites on serum albumins and their interplay with fatty acids. Chem. Sci. 2023;14(23):6244\u20136258.", "ArticleIdList": ["PMC10266443", "37325156"]}, {"Citation": "Wunder A., Muller-Ladner U., Stelzer E., Neumann E., Sinn H., Gay S., et al. Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis. Arthritis Res. Ther. 2003;5(Suppl. 3):1.", "ArticleIdList": ["12707361"]}, {"Citation": "Xue C., Zhang R., Liu H., Yao X., Liu M., Hu Z., et al. QSAR models for the prediction of binding affinities to human serum albumin using the heuristic method and a support vector machine. J. Chem. Inf. Comput. Sci. 2004;44(5):1693\u20131700.", "ArticleIdList": ["15446828"]}, {"Citation": "Yabu Y., Miyai K., Kobayashi A., Miki K., Doi K., Takamatsu J., et al. A new type of albumin with predominantly increased binding affinity for 3, 3\u2032, 5-triiodothyronine in a patient with Graves' disease. J. Endocrinol. Invest. 1987;10(2):163\u2013169.", "ArticleIdList": ["3584855"]}, {"Citation": "Yamasaki K., Maruyama T., Kragh-Hansen U., Otagiri M. Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 1996;1295(2):147\u2013157.", "ArticleIdList": ["8695640"]}, {"Citation": "Yeun J.Y., Kaysen G.A. Factors influencing serum albumin in dialysis patients. Am. J. Kidney Dis. 1998;32(6):S118\u2013S125.", "ArticleIdList": ["9892378"]}, {"Citation": "Zeeshan F., Madheswaran T., Panneerselvam J., Taliyan R., Kesharwani P. Human serum albumin as multifunctional nanocarrier for cancer therapy. J. Pharmaceut. Sci. 2021;110(9):3111\u20133117.", "ArticleIdList": ["33989679"]}, {"Citation": "Zhu L., Yang F., Chen L., Meehan E.J., Huang M. A new drug binding subsite on human serum albumin and drug\u2013drug interaction studied by X-ray crystallography. J. Struct. Biol. 2008;162(1):40\u201349.", "ArticleIdList": ["18258455"]}, {"Citation": "Zsila F. Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model. Mol. Pharm. 2013;10(5):1668\u20131682.", "ArticleIdList": ["23473402"]}, {"Citation": "Zunszain P.A., Ghuman J., McDonagh A.F., Curry S. Crystallographic analysis of human serum albumin complexed with 4Z, 15E-bilirubin-IX\u03b1. J. Mol. Biol. 2008;381(2):394\u2013406.", "ArticleIdList": ["PMC2568863", "18602119"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "12"}, {"Year": "2023", "Month": "11", "Day": "21"}, {"Year": "2023", "Month": "11", "Day": "22"}, {"Year": "2023", "Month": "12", "Day": "19", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "19", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "12", "Day": "19", "Hour": "4", "Minute": "3"}, {"Year": "2023", "Month": "11", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["38111902", "PMC10726258", "10.1016/j.crstbi.2023.100114", "S2665-928X(23)00020-X"]}}], "PubmedBookArticle": []}